Vaxart, Inc. Liabilities, Noncurrent
Vaxart, Inc. (VXRT) had Liabilities, Noncurrent of $296.00 thousand as of 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2013-05-10
- 2013-03-31: Liabilities, Noncurrent $296.00K.
- 2012-12-31: Liabilities, Noncurrent $275.00K.
- 2012-06-30: Liabilities, Noncurrent $504.00K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2013-03-31 | $296.00K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $275.00K 10-Q · filed 2013-02-11 |
| 2012-06-30 | $504.00K 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |